Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieHumansAdrenocortical CarcinomaCell LineTumorReceptors
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma.
Sara Taranto, Jessica Faletti, Mariangela Tamburello, Roberto Ronca, Giulia Garattini, Giorgia Gazzaroli, Marta Turati, Edoardo Rocca, Riccardo Castelli, Andrea Abate, Luca Mignani, Marta Laganà, Constanze Hantel, Sandra Sigala, Marco Presta
Published: 202510.1016/j.biopha.2025.118677
Abstract
Adrenocortical carcinoma (ACC) is a rare endocrine neoplastic disease that originates from the cortical cortex of adrenal gland. Unfortunately, after complete resection of the tumor, ACC relapses either locally or with distant metastasis in about 74…
Preview only. Read the full abstract at the source